Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study

OBJECTIVES: Methotrexate (MTX) is the most commonly used cost-effective disease-modifying antirheumatoid drug (DMARD). Its main dose-limiting adverse effects are hepatic and hematopoietic. This cross-sectional, observational study evaluated the prevalence of hepatic and hematological adverse effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubey, Lily, Chatterjee, Suparna, Ghosh, Alakendu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051257/
https://www.ncbi.nlm.nih.gov/pubmed/27721549
http://dx.doi.org/10.4103/0253-7613.190761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5051257/
https://www.ncbi.nlm.nih.gov/pubmed/27721549
http://dx.doi.org/10.4103/0253-7613.190761

Ejemplares similares